Product Description
1,3,4,5-tetrahydro-2H-1,5-methanobenzo[d]azepin-2-one、357426-13-2
AI Product Description
*The following content is generated by AI and is for reference only.
1,3,4,5-Tetrahydro-2H-1,5-methanobenzo[d]azepin-2-one is a specialized heterocyclic organic compound characterized by a fused tricyclic structure combining a benzene ring with a seven-membered azepine ring containing a bridged methylene group and a lactam functionality. Its molecular formula is C₁₂H₁₃NO₂, corresponding to a molecular weight of approximately 203.24 g/mol. While specific CAS registry numbers for this precise isomer may vary depending on the exact stereochemical configuration or commercial listing availability, it generally falls under the classification of complex nitrogen-containing heterocycles often utilized in advanced chemical research. This molecule serves as a critical intermediate in medicinal chemistry and organic synthesis, particularly in the development of novel pharmaceutical agents targeting the central nervous system. The rigid bicyclic framework provides unique steric constraints that are highly valuable for designing ligands with high binding affinity and selectivity for specific biological receptors. Researchers frequently employ this scaffold to explore structure-activity relationships (SAR) when creating new analgesics, anxiolytics, or anticonvulsants. Furthermore, its lactam moiety offers versatile sites for further derivatization, allowing chemists to attach various functional groups to modulate pharmacokinetic properties such as solubility, metabolic stability, and bioavailability. In materials science, derivatives of this core structure may also find niche applications in the synthesis of specialized polymers or chiral catalysts due to their distinct geometric features. Despite its potential, the compound is primarily available through specialized chemical suppliers for academic and industrial R&D purposes rather than as a bulk commodity. Safety data sheets indicate standard precautions for handling organic solids, including avoidance of inhalation and skin contact. As synthetic methodologies evolve, this compound remains a subject of interest for expanding the library of privileged structures in drug discovery, offering a promising pathway toward next-generation therapeutics with improved efficacy profiles.